Hydromorphone Hydrochloride 13107-0109-20
- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 17, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA205814
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 8 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
13107-0109-20Selected20 TABLET in 1 BOTTLE (13107-109-20)
Other packages for this product(3)
100 TABLET in 1 BOTTLE (13107-109-01)
500 TABLET in 1 BOTTLE (13107-109-05)
1000 TABLET in 1 BOTTLE (13107-109-99)